Virtu Financial LLC grew its position in shares of Atossa Therapeutics, Inc. (NASDAQ:ATOS – Free Report) by 311.1% during the ...
Equities research analysts at HC Wainwright increased their Q1 2025 earnings estimates for Atossa Therapeutics in a note ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback